{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:24:23Z","timestamp":1781774663101,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd006949","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T00:00:00Z","timestamp":1247011200000}}],"reference-count":85,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006949.pub2","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T11:11:38Z","timestamp":1246619498000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Interventions for erythema nodosum leprosum"],"prefix":"10.1002","volume":"2012","author":[{"given":"Natasja HJ","family":"Van Veen","sequence":"first","affiliation":[{"name":"Erasmus Medical Center; Department of Public Health; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana NJ","family":"Lockwood","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Department of Infectious Diseases; Keppel Street London UK WC1E 7HT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim H","family":"van Brakel","sequence":"additional","affiliation":[{"name":"Royal Tropical Institute; Leprosy Unit; Wibautstraat 137J Amsterdam Netherlands 1079 DN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Ramirez Jr","sequence":"additional","affiliation":[{"name":"University of Nottingham; c\/o Cochrane Skin Group; King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hendrik","family":"Richardus","sequence":"additional","affiliation":[{"name":"Erasmus Medical Center; Department of Public Health; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0001|cit1","first-page":"17","article-title":"Levamisole in cases of E.N.L","volume":"57","author":"Arora","year":"1985","journal-title":"Indian Journal of Leprosy"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0002|cit2","first-page":"233","article-title":"Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study","volume":"74","author":"Girdhar","year":"2002","journal-title":"Indian Journal of Leprosy"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0003|cit3","first-page":"167","article-title":"Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial","volume":"42","author":"Helmy","year":"1971","journal-title":"Leprosy Review"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0004|cit4","first-page":"66","article-title":"Indomethacin in the treatment of erythema nodosum leprosum, in comparison with prednisolone","volume":"10","author":"Ing","year":"1969","journal-title":"Singapore Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD006949.pub2-BIB0005|cit5","first-page":"719","article-title":"WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients","volume":"45","author":"Iyer","year":"1971","journal-title":"Bulletin of the World Health Organization"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD006949.pub2-BIB0006|cit6","first-page":"690","article-title":"An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug","volume":"48","author":"Iyer","year":"1976","journal-title":"Lepra in India"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5935\/0305-7518.19690027","article-title":"Indomethacin in the management of erythema nodosum leprosum--a double-blind controlled trial","volume":"40","author":"Karat","year":"1969","journal-title":"Leprosy Review"},{"issue":"5690","key":"10.1002\/14651858.CD006949.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bmj.1.5690.198","article-title":"Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy","volume":"1","author":"Karat","year":"1970","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5935\/0305-7518.19690022","article-title":"Treatment of moderately severe erythema nodosum leprosum with thalidomide - a double-blind controlled trial","volume":"40","author":"Pearson","year":"1969","journal-title":"Leprosy Review"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0010|cit10","first-page":"243","article-title":"Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy","volume":"40","author":"Sales","year":"2007","journal-title":"Brazilian Journal of Medical and Biological Research = Revista brasileira de pesquisas m\u00e9dicas e biol\u00f3gicas \/ Sociedade Brasileira de Biof\u00edsica ... [et al.]"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0011|cit11","first-page":"135","article-title":"Results of a double-blind study of the influence of thalidomide on the lepra reaction","volume":"37","author":"Sheskin","year":"1969","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006949.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.2005.72.518","article-title":"A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum","volume":"72","author":"Villahermosa","year":"2005","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5935\/0305-7518.19710004","article-title":"An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum","volume":"42","author":"Waters","year":"1971","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4269\/ajtmh.1976.25.437","article-title":"Spaced clofazimine therapy of lepromatous leprosy","volume":"25","author":"Anonymous","year":"1976","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/S0036-46651986000100003","article-title":"Effect of thalidomide on serum levels of immunoglobulins IgM and IgA, rheumatoid factor and isohemagglutinins anti-A and anti-B in patients with lepromatous leprosy. A double-blind study","volume":"28","author":"Arruda","year":"1986","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0016|cit16","first-page":"167","article-title":"Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978","volume":"49","author":"Browne","year":"1981","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0017|cit17","first-page":"38","article-title":"A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions","volume":"70","author":"Dawlah","year":"2002","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.47878\/hi.1981.v6.36114","article-title":"Comparative study of the therapeutic activity of glutamic acid phthalimide and the therapeutic activity of triamcinolone in the treatment of Hansen's reaction of Virchowian Leprosy","volume":"6","author":"Almeida Neto","year":"1981","journal-title":"Hansenologia Internationalis"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1346-8138.2003.tb00335.x","article-title":"Pentoxifylline in the treatment of erythema nodosum leprosum","volume":"30","author":"Carsalade","year":"2003","journal-title":"Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0020|cit20","first-page":"117","article-title":"Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study","volume":"12","author":"Carsalade","year":"2003","journal-title":"Acta Leprologica"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0021|cit21","unstructured":"Garbino JA Clinical and neurophysiologic randomized trial about ulnar neuropathy responses, in type 1 and type 2 Hansen's disease reactions under oral steroid treatment Thesis 2006"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cpt1970114481","article-title":"Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum","volume":"11","author":"Hastings","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0023|cit23","first-page":"163","article-title":"Treatment of type II lepra reaction with Tripterygium Wilfordii Hook F(leigongteng) and thalidomide (Chinese)","volume":"3","author":"Huang","year":"1987","journal-title":"Journal of Chinese leprosy"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5935\/0305-7518.19680022","article-title":"A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663)","volume":"39","author":"Imkamp","year":"1968","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5935\/0305-7518.19730019","article-title":"The treatment of corticosteroid-dependent lepromatous patients in persistent Erythema nodosum leprosum with clofazimine","volume":"44","author":"Imkamp","year":"1973","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0026|cit26","first-page":"542","article-title":"Short-term trial of clofazimine in previously untreated lepromatous leprosy","volume":"60","author":"Jamet","year":"1992","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5935\/0305-7518.19880025","article-title":"Comparison of colchicine and aspirin in the treatment of type 2 lepra reaction","volume":"59","author":"Kar","year":"1988","journal-title":"Leprosy Review"},{"issue":"5786","key":"10.1002\/14651858.CD006949.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bmj.4.5786.514","article-title":"Controlled clinical trial of clofazimine in untreated lepromatous leprosy","volume":"4","author":"Karat","year":"1971","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0029|cit29","first-page":"838","article-title":"Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy","volume":"39","author":"Karat","year":"1971","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"7824","key":"10.1002\/14651858.CD006949.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(73)90829-5","article-title":"Treatment of erythema nodosum leprosum with thalidomide","volume":"2","author":"Levy","year":"1973","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD006949.pub2-BIB0031|cit31","first-page":"209","article-title":"A comparison of the incidence of type 2 reactions in lepromatous leprosy with two regimens of treatment","volume":"28","author":"Manungo","year":"1982","journal-title":"Central African Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006949.pub2-BIB0032|cit32","first-page":"211","article-title":"A study of type 2 reactions in lepromatous leprosy","volume":"28","author":"Manungo","year":"1982","journal-title":"Central African Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0033|cit33","first-page":"61","article-title":"Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL","volume":"66","author":"Moreira","year":"1998","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000023926","article-title":"IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment","volume":"116","author":"Partida-Sanchez","year":"1998","journal-title":"International Archives of Allergy and Immunology"},{"issue":"5","key":"10.1002\/14651858.CD006949.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1590\/S0365-05962005000600010","article-title":"Thalidomide in the treatment of erythema nodosum leprosum (ENL): Systematic review of clinical trials and prospects of new investigations","volume":"80","author":"Penna","year":"2005","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0036|cit36","first-page":"11","article-title":"The treatment of erythema nodosum leprosum with B.663. A controlled study","volume":"35","author":"Pettit","year":"1967","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5935\/0305-7518.19760004","article-title":"A long term trial with clofazimine in reactive lepromatous leprosy","volume":"47","author":"Plock","year":"1976","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0038|cit38","first-page":"497","article-title":"Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine","volume":"51","author":"Ramu","year":"1979","journal-title":"Leprosy in India"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0039|cit39","first-page":"276","article-title":"Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy","volume":"42","author":"Rodriguez","year":"1974","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0040|cit40","first-page":"159","article-title":"Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL)","volume":"50","author":"Sharma","year":"1982","journal-title":"International Journal of Leprosy & Other Mycobacterial Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0041|cit41","first-page":"43","article-title":"Colchicine in the treatment of type 2 lepra reaction","volume":"58","author":"Sharma","year":"1986","journal-title":"Indian Journal of Leprosy"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0042|cit42","first-page":"359","article-title":"Motor conduction velocity studies in patients with leprosy reaction treated with thalidomide and other drugs","volume":"37","author":"Sheskin","year":"1969","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0043|cit43","first-page":"585","article-title":"Five years' experience with thalidomide treatment in leprosy reaction","volume":"39","author":"Sheskin","year":"1971","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0044|cit44","first-page":"168","article-title":"Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?","volume":"34","author":"Sheskin","year":"1983","journal-title":"Hautarzt"},{"issue":"5","key":"10.1002\/14651858.CD006949.pub2-BIB0045|cit45","first-page":"478","article-title":"Clofazimine. Current status of therapy with clofazimine (Lampren) for leprosy, erythema leprosum, and other dermatoses after donation of the medicine to the WHO by Novartis","volume":"56","author":"Sunderkotter","year":"2005","journal-title":"Hautarzt"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0046|cit46","first-page":"71","article-title":"Effect of zafirlukast on leprosy reactions","volume":"67","author":"Vides","year":"1999","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5935\/0305-7518.19930002","article-title":"Immunotherapy with Mycobacterium w vaccine decreases the incidence and severity of type 2 (ENL) reactions","volume":"64","author":"Zaheer","year":"1993","journal-title":"Leprosy Review"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0048|cit48","unstructured":"Zhang Z Therapeutic effect observation of ENL reaction treated with combination of traditional Chinese and Western medicine Abstracts of the 17th International Leprosy Congress Hyderabad, India 2008"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0049|cit49","unstructured":"Salim AH Montelukast in ENL reaction Available from http:\/\/clinicaltrials.gov\/show\/NCT00406861"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5935\/0305-7518.19740015","article-title":"A clinical study of the nose in lepromatous leprosy","volume":"45","author":"Barton","year":"1974","journal-title":"Leprosy Review"},{"issue":"7","key":"10.1002\/14651858.CD006949.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMc052955","article-title":"Treatment of recurrent erythema nodosum leprosum with infliximab","volume":"355","author":"Faber","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1128\/CMR.1.3.330","article-title":"Leprosy","volume":"1","author":"Hastings","year":"1988","journal-title":"Clinical Microbiology Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1489\/1544-581X(2004)72<437:TDOSIL>2.0.CO;2","article-title":"The dynamics of stigma in leprosy","volume":"72","author":"Heijnders","year":"2004","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0054|cit54","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 5.0.1 [updated September 2008]","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0055|cit55","unstructured":"The International Federation of Anti-Leprosy Associations (ILEP) The management of erythema nodosum leprosum ILEP Technical Bulletin 1996"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0056|cit56","volume-title":"How to diagnose and treat leprosy","author":"The International Federation of Anti-Leprosy Associations (ILEP)","year":"2001"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0057|cit57","volume-title":"How to recognise and manage reactions","author":"The International Federation of Anti-Leprosy Associations (ILEP)","year":"2002"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.2008.78.518","article-title":"Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR","volume":"78","author":"Job","year":"2008","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.trstmh.2008.01.004","article-title":"Towards understanding the pathology of erythema nodosum leprosum","volume":"102","author":"Kahawita","year":"2008","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1489\/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2","article-title":"Epidemiological characteristics of leprosy reactions: 15 years experience from north India","volume":"72","author":"Kumar","year":"2004","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5935\/0305-7518.19960026","article-title":"The management of erythema nodosum leprosum: current and future options","volume":"67","author":"Lockwood","year":"1996","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.47276\/lr.78.4.317","article-title":"Classifying leprosy patients--searching for the perfect solution?","volume":"78","author":"Lockwood","year":"2007","journal-title":"Leprosy Review"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0064|cit64","first-page":"51","article-title":"Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study","volume":"66","author":"Mahajan","year":"1994","journal-title":"Indian Journal of Leprosy"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0065|cit65","first-page":"270","article-title":"Risk factors for erythema nodosum leprosum","volume":"67","author":"Manandhar","year":"1999","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0066|cit66","first-page":"330","article-title":"Reactions: the body as battlefield I: clinical aspects","volume":"69","author":"Naafs","year":"2003","journal-title":"Memisa Medisch"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0067|cit67","first-page":"337","article-title":"Reactions: the body as battlefield II: immunopathology","volume":"69","author":"Naafs","year":"2003","journal-title":"Memisa Medisch"},{"issue":"6","key":"10.1002\/14651858.CD006949.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S0036-46651998000600005","article-title":"Reactional states in multibacillary Hansen disease patients during multidrug therapy","volume":"40","author":"Nery","year":"1998","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0069|cit69","first-page":"457","article-title":"The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy","volume":"72","author":"Nery","year":"2000","journal-title":"Indian Journal of Leprosy"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0070|cit70","first-page":"97","article-title":"Does droplet infection play a role in the transmission of leprosy?","volume":"47","author":"Pedly","year":"1976","journal-title":"Leprosy Review"},{"issue":"5","key":"10.1002\/14651858.CD006949.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4269\/ajtmh.2006.74.868","article-title":"Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India","volume":"74","author":"Pocaterra","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD006949.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.47276\/lr.76.2.119","article-title":"Curing the stigma of leprosy","volume":"76","author":"Rafferty","year":"2005","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0073|cit73","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5935\/0305-7518.20000035","article-title":"ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors","volume":"71","author":"Saunderson","year":"2000","journal-title":"Leprosy Review"},{"issue":"4","key":"10.1002\/14651858.CD006949.pub2-BIB0075|cit75","first-page":"339","article-title":"Special workshop on repeated and late reactions","volume":"70","author":"Smith","year":"2002","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"issue":"11","key":"10.1002\/14651858.CD006949.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.4049\/jimmunol.137.11.3620","article-title":"Effect of cyclosporine A in erythema nodosum leprosum","volume":"137","author":"Uyemura","year":"1986","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0077|cit77","first-page":"277","article-title":"The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India","volume":"76","author":"Brakel","year":"2005","journal-title":"Leprosy Review"},{"issue":"3","key":"10.1002\/14651858.CD006949.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.47276\/lr.78.3.197","article-title":"The role of thalidomide in the management of erythema nodosum leprosum","volume":"78","author":"Walker","year":"2007","journal-title":"Leprosy Review"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0079|cit79","unstructured":"World Health Organization WHO Guidelines for the management of severe erythema nodosum leprosum (ENL) reactions Available from http:\/\/www.who.int\/lep\/research\/WHOenlguide.pdf"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0080|cit80","first-page":"1","article-title":"WHO Expert Committee on Leprosy","volume":"874","author":"World Health Organization","year":"1998","journal-title":"World Health Organization Technical Report Series"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0081|cit81","volume-title":"Guide to Eliminate Leprosy as a Public Health Problem","author":"World Health Organization","year":"2000"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0082|cit82","volume-title":"The Final Push Strategy to Eliminate Leprosy as a Public Health Problem. Questions and Answers","author":"World Health Organization","year":"2003"},{"key":"10.1002\/14651858.CD006949.pub2-BIB0083|cit83","unstructured":"World Health Organization Leprosy Available from http:\/\/www.who.int\/mediacentre\/factsheets\/fs101\/en\/index.html"},{"issue":"33","key":"10.1002\/14651858.CD006949.pub2-BIB0084|cit84","first-page":"293","article-title":"Global leprosy situation, beginning of 2008","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Weekly Epidemiological Record"},{"issue":"1","key":"10.1002\/14651858.CD006949.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5935\/0305-7518.19930002","article-title":"Immunotherapy with Mycobacterium w vaccine decreases the incidence and severity of type 2 (ENL) reactions","volume":"64","author":"Zaheer","year":"1993","journal-title":"Leprosy Review"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006949.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:12:22Z","timestamp":1734912742000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006949.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":85,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006949.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,8]]}}}